Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - July 2013


Payer Strategies for Emerging Markets

30 Jul 2013 - 01 Aug 2013 - Philadelphia, PA, USA



Bookmark and Share


Emerging markets are moving up the agenda of pharma and global healthcare organizations. Yet many regions are still unchartered territory and are difficult to navigate. To build effective strategic partnerships and drive the most profitable performance, you need to understand the dynamics that make these regions so challenging, yet full of potential...

That means the payers. What they need.  How they need it.  When they need it.

Payer Strategies for Emerging Markets will set you up to execute the most successful product launches in the world’s key growth markets.  Learn to manage the transformation of your traditional pharmaceutical business model to one that really takes hold in the world’s key growth economies.

This meeting will provide you with the clarity you need to demonstrate maximum product value to payers in emerging markets. The agenda has been designed in collaboration with leaders from organizations like Pfizer, Abbott, World Bank, Novartis, Merck and the World Health Organization.

Build solid payer-industry partnerships at this highly interactive forum. Payer Strategies for Emerging Markets was created for you to meet the key stakeholders who can give you the gold standard business intelligence to adapt your market access approach in different regions.

Meet pharma, payer organizations and key solution providers. This meeting lets you use these relationships to refine your product launch strategy and strengthen the foundation for commercial success in emerging markets.

At the meeting you will…

Gain an insight into regional price containment strategies. Avoid the hurdles to maximize impact at product launch

Ensure maximum patient compliance.  Find out how to best engage with an out of pocket payer in a changing health economic environment

Keep early value demonstration front of mind when preparing healthcare authorities for your product hitting the market

Develop actionable pricing and reimbursement strategies for streamlined access in emerging markets

Adapt your marketing approach and design your distribution strategies to meet the needs of both the public and private payer for long-term, regional, profitable success

Discover the benefits of local and corporate team integration to avoid a culture clash when accessing emerging markets

Understand the importance of a clear launch strategy for optimal product development and distribution in emerging markets

Payer Strategies for Emerging Markets will equip you with the knowledge and tools to boost business in key growth economies.  Get an understanding of the payers and develop unique strategies to adapt and optimize your access approach in emerging markets.

Who you’ll meet…

Pharmaceutical Companies: Heads of Marketing, Pricing, Reimbursement, Medical Affairs and Market Access looking to partner with payers and plan developers to optimize reimbursement and build strategic relationships

Payers and Plan Developers: Group Directors and Managers looking to gain a more thorough understanding of the access and pricing environment and form strategic partnerships with pharma

Market Access Consultancies: Vice President of Sales and Marketing and Directors of Business Development keen to generate new business, successfully collaborate with industry leaders and stay front-of-mind when pharma look to source consultants




Further information
Scientific News
Breast Cancer Drug Hope
A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research.
A New Platform for Discovering Antibiotics
Harvard chemists hope to shorten time, difficulty in measuring their effectiveness, potential.
Non-Toxic Approach to Treating Variety of Cancers
A team of researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine recently discovered a novel, non-toxic approach to treating a wide variety of cancers.
Making Injectable Medicine Safer
Researchers remove excess additives from drugs, which could reduce the odds of serious allergic reactions and other side effects.
Turning Skin Cells into Heart, Brain Cells
In a major breakthrough, scientists at the Gladstone Institutes transformed skin cells into heart cells and brain cells using a combination of chemicals.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Doubling Down on Dengue
HMS researchers have discovered two ways a compound blocks dengue virus.
Reprogramming Scorpion Venom
‘Twist of nature’ neutralizes toxin.
Tailoring a Suit for Tumor-Penetrating Cancer Meds
For more than a decade, biomedical researchers have been looking for better ways to deliver cancer-killing medication directly to tumors in the body.
Resurrecting an Abandoned Drug
Previously discarded drug shows promise in helping human cells in a lab dish fight off two different viruses.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,100+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!